Home
>
National Drug Code (NDC)
>
Candesartan Cilexetil-Hydrochlorothiazide
Candesartan Cilexetil-Hydrochlorothiazide - 49884-664-09 - (Candesartan Cilexetil Hydrochlorothiazide)
Drug Information of Candesartan Cilexetil-Hydrochlorothiazide
| Product NDC: | 49884-664 |
| Proprietary Name: | Candesartan Cilexetil-Hydrochlorothiazide |
| Non Proprietary Name: | Candesartan Cilexetil Hydrochlorothiazide |
| Active Ingredient(s): | 32; 25 mg/1; mg/1 & nbsp; Candesartan Cilexetil Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Candesartan Cilexetil-Hydrochlorothiazide
| Product NDC: | 49884-664 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021093 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20121205 |
Package Information of Candesartan Cilexetil-Hydrochlorothiazide
| Package NDC: | 49884-664-09 |
| Package Description: | 90 TABLET in 1 BOTTLE (49884-664-09) |
NDC Information of Candesartan Cilexetil-Hydrochlorothiazide
| NDC Code | 49884-664-09 |
| Proprietary Name | Candesartan Cilexetil-Hydrochlorothiazide |
| Package Description | 90 TABLET in 1 BOTTLE (49884-664-09) |
| Product NDC | 49884-664 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Candesartan Cilexetil Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121205 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE |
| Strength Number | 32; 25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
